Interview with Kitima Yuthavong, CEO, PREMA Thailand
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Address: 408/85, 19th Floor, Phaholyothin Place Bldg. Phaholyothin Road Samsennai, Phayathai Bangkok 10400,Thailand
Tel: (02) 619-0232
PREMA is a non-profit organization representing members who are research based pharmaceutical companies innovating medicines to combat the previously incurable diseases and to improve on existing treatments.
The Pharmaceutical Research and Manufacturers Association (PReMA) is dedicated to promoting good health and quality of life for the Thai people and to support the advancement of public health systems through the research and development of innovative medicines. PReMA also supports the rights to choice by the people and the healthcare professionals to high quality medicines that best meet their needs.
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Through compassionate use programs patients suffering from critical, life-threatening conditions can access potential life-saving therapeutic options which have not been formally approved by the responsible health authority in an ethical…
Takeda’s Soon Yee Chow and Helene Sou, writing in the September 2022 edition of DIA’s Global Forum magazine, outline how digitalisation initiatives, if properly enacted, can help the ASEAN region…
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download now. Thailand is in the midst of an economic transformation with healthcare at its heart. With four years…
Shinsuke Yuasa, president of Thai Otsuka discusses the importance of Thailand for Otsuka as its first overseas market back in 1973. Yuasa goes on to highlight how the affiliate is…
Thailand country managers from three of the world’s largest medtech firms outline the level of innovation they are able to bring to the Thai market, how their technology is helping…
Nico Form-Zuellig, general manager of Interthai Pharmaceutical Manufacturing, shares his thoughts on the Thai pharmaceutical market as a newcomer to the country and goes on to elaborate on the company’s…
Philippe Pedeboscq, managing director of Siemens Healthineers, shares his impressions after taking the lead of the company’s Thailand affiliate two years ago. Pedeboscq goes on to explain his strategic mission…
Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma multinationals in Thailand. Upon this solid foundation, Novo…
Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life Science (TCELS) since its foundation in 2004. After seven years onboard, he discusses the organization’s progress…
See our Cookie Privacy Policy Here